KKR Phorm Investors L.P. 13D and 13G filings for Transphorm, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-20 4:30 pm Sale | 2024-06-20 | 13D | Transphorm, Inc. TGAN | KKR Phorm Investors L.P. | 0 0.000% | -24,724,468 (Position Closed) | Filing |
| 2024-01-11 4:40 pm Unchanged | 2024-01-10 | 13D | Transphorm, Inc. TGAN | KKR Phorm Investors L.P. | 24,724,468 39.700% | 0 (Unchanged) | Filing |
| 2023-07-25 4:19 pm Purchase | 2023-07-21 | 13D | Transphorm, Inc. TGAN | KKR Phorm Investors L.P. | 24,724,468 39.800% | 1,735,988 (+7.55%) | Filing |
| 2022-06-03 4:30 pm Purchase | 2022-06-01 | 13D | Transphorm, Inc. TGAN | KKR Phorm Investors L.P. | 22,988,480 40.400% | 22,988,480 (New Position) | Filing |